Quick Answer
NEUROONE MEDICAL TECHNOLOGIES Corp reported Gross Profit of $5.14 million for the year ending 2025.
- NEUROONE MEDICAL TECHNOLOGIES Corp showed an increase of +376.2% in Gross Profit from 2024 to 2025.
- This data is from NEUROONE MEDICAL TECHNOLOGIES Corp's annual report (Form 10-K), filed with the SEC on December 17, 2025.
- XBRL data for this metric is available from 2010 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: $3.1 thousand | Q2 2011: $1.2 thousand | Q3 2011: $812.00 | Q1 2012: $147.00 | Q2 2012: $391.00 | Q3 2012: $23.00 | Q1 2013: $406.00 | Q2 2013: $451.00 | Q3 2013: $252.00 | Q1 2014: $165.00 | Q2 2014: $303.00 | Q3 2014: $139.00 | Q4 2020: -$37.7 thousand | Q1 2021: -$21.1 thousand | Q2 2021: -$21.8 thousand | Q4 2021: -$13.1 thousand | Q1 2022: -$36.2 thousand | Q2 2022: -$6.4 thousand | Q4 2022: -$12.3 thousand | Q1 2023: $31.5 thousand | Q2 2023: $243.7 thousand | Q4 2023: $266.3 thousand | Q1 2024: $390.4 thousand | Q2 2024: $281.9 thousand | Q4 2024: $1.93 million | Q1 2025: $771.1 thousand | Q2 2025: $914.8 thousand | Q4 2025: $1.57 million.
- Over the full 8 years of available data (2010 to 2025), NEUROONE MEDICAL TECHNOLOGIES Corp's Gross Profit has grown by 440,466.1%.
- Historical annual values: Fiscal year 2025: $5.14 million | Fiscal year 2024: $1.08 million | Fiscal year 2023: $456.5 thousand | Fiscal year 2022: -$70.8 thousand | Fiscal year 2021: -$97.7 thousand | Fiscal year 2012: $921.00 | Fiscal year 2011: $3.3 thousand | Fiscal year 2010: $1.2 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: